Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Anxiety, Depression May Help Predict Outcome of Low Back Pain Treatment

Lorraine L. Janeczko  |  July 31, 2018

NEW YORK (New York)—Patients with anxiety and depression may be less satisfied than other patients with their chronic low back pain (CLBP) treatments, new research suggests. “Patients with anxiety/depression symptoms experienced more pain severity and more pain-related functional, social, and emotional disability, and they were less satisfied with care, compared with the other groups,” the…

Filed under:ConditionsPain Syndromes Tagged with:anxiety disordersBack painChronic painDepressionlow back painPain Management

Study Supports Safety of Infliximab in Pregnancy

Reuters Staff  |  July 31, 2018

NEW YORK (Reuters Health)—New registry data should help reassure women with Crohn’s disease (CD) who need to continue infliximab during pregnancy that it won’t harm their baby. “The clinical condition of infants born to women with gestational infliximab exposure was similar to those without exposure,” the study team reports online July 19 in the American…

Filed under:Conditions Tagged with:Crohn's diseaseinfantsinfliximabpregnancy

Nurse Practitioners Provide Advanced Care & Support

Karen Appold  |  July 30, 2018

With their ability to provide treatment and manage chronic illnesses, nurse practitioners can aid rheumatologists in the care of their patients…

Filed under:Conditions Tagged with:healthcare teamnurse practitionerpatient carePractice Management

Long-Term Apremilast Promising for Psoriatic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  July 27, 2018

In a long-term study, apremilast was well tolerated by patients with psoriatic arthritis, who showed sustained improvements for up to five years…

Filed under:Drug Updates Tagged with:apremilastPsoriatic Arthritis

Private Practice in Rheumatology: Winners & Losers in the Workforce Numbers Game

Carina Stanton  |  July 25, 2018

In the U.S., the demand for rheumatologists has outpaced the supply of physicians. So how do private practices attract new physicians, and how are practices with physician vacancies managing?

Filed under:Practice SupportWorkforce Tagged with:Practice Managementrecruitmentrheumatologistsworkforce developmentworkforce shortageWorkforce Study

Upadacitinib Promising for RA Patients

Michele B. Kaufman, PharmD, BCGP  |  July 23, 2018

Upadacitinib proved safe and effective in RA patients who had inadequate responses to conventional disease-modifying anti-rheumatic drugs…

Filed under:Drug Updates Tagged with:Rheumatoid Arthritis (RA)upadacitinib

2018 ACR/ARHP Annual Meeting Courses, Opening Lecture & Keynote

From the College  |  July 19, 2018

Join us in Chicago for the 2018 ACR/ARHP Annual Meeting on Oct. 19–24. Register now to save; advance registration rates end Oct. 3. High-Impact Learning Starts with Pre-Meeting Courses Pre-meeting courses offer attendees unique learning opportunities in specific topic areas. The pre-meeting courses will be held at McCormick Place Oct. 19–20. No matter your area…

Filed under:From the College Tagged with:2018 ACR/ARHP Annual Meeting

Rheumatologist Spotlight: Robert Simms, MD, Triathlete

Carol Patton  |  July 19, 2018

Every single morning—even on weekends—Robert W. Simms, MD, wakes up at 3:45 and is out the door by 4:30 to swim, run or cycle for at least one hour. After weekday workouts, he then heads to his job at Boston University (BU) School of Medicine, where he serves as professor of medicine and rheumatology section…

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Robert W. Simms

Study Finds Eating Fresh Fish May Ease Rheumatoid Arthritis Symptoms

Linda Childers  |  July 19, 2018

Could relief for rheumatoid arthritis (RA) symptoms be as close as the nearest seafood restaurant? Possibly, say researchers from Harvard. University who recently conducted a cross-sectional study. Published in the March issue of Arthritis Care & Research, the research examined whether consuming fresh fish could ease RA symptoms.1 Previous studies have examined the role fish…

Filed under:ConditionsRheumatoid Arthritis Tagged with:DietMediterranean diet

Epratuzumab May Work for SLE Subgroups

Larry Beresford  |  July 19, 2018

A recent analysis of the monoclonal antibody epratuzumab finds new evidence for its effectiveness in a subset of systemic lupus erythematosus (SLE) patients who have a concurrent diagnosis of Sjögren’s syndrome, a progressive autoimmune disease that affects exocrine glands and is characterized by dry eyes and mouth.1 Sjögren’s can be primary, meaning independent of other…

Filed under:ConditionsSjögren’s DiseaseSystemic Lupus Erythematosus Tagged with:epratuzumabLymphoCideSjogren's

  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences